A phase II study of binimetinib plus imatinib in patients with unresectable KIT-mutant melanoma.

Authors: Katy K. Tsai, Gregory A. Daniels, Marjan Rajabi, Nicholas Lee, Adil Daud, Iwei Yeh

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps9605

Source: Full article

---

Abstract

TPS9605